153 related articles for article (PubMed ID: 25197383)
1. Association of pancreatic adenocarcinoma up-regulated factor expression in ovarian mucinous adenocarcinoma with poor prognosis.
Kim SK; Song SY; Kim S; Cho NH; Yim GW; Kim SW; Kim YT; Nam EJ
Int J Clin Exp Pathol; 2014; 7(8):5103-10. PubMed ID: 25197383
[TBL] [Abstract][Full Text] [Related]
2. HER2-positive mucinous adenocarcinomas of the ovary have an expansile invasive pattern associated with a favorable prognosis.
Kim SK; Cho NH
Int J Clin Exp Pathol; 2014; 7(7):4222-30. PubMed ID: 25120802
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic adenocarcinoma up-regulated factor has oncogenic functions in oral squamous cell carcinoma.
Sasahira T; Kurihara M; Nishiguchi Y; Nakashima C; Kirita T; Kuniyasu H
Histopathology; 2017 Mar; 70(4):539-548. PubMed ID: 27706833
[TBL] [Abstract][Full Text] [Related]
4. Expression of hepatocyte nuclear factor 4 alpha in primary ovarian mucinous tumors.
Sugai M; Umezu H; Yamamoto T; Jiang S; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
Pathol Int; 2008 Nov; 58(11):681-6. PubMed ID: 18844932
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous mucinous cystadenoma of ovary and mucinous cystadenocarcinoma of pancreas.
Gagne LJ; Colacchio T; Longnecker DS
Int J Pancreatol; 2000 Aug; 28(1):9-13. PubMed ID: 11185714
[TBL] [Abstract][Full Text] [Related]
6. [Mucinous ovarian neoplasms. Prognostically mostly excellent, infrequently a wolf in sheep's clothing].
Lax S; Staebler A
Pathologe; 2014 Jul; 35(4):327-35. PubMed ID: 24962632
[TBL] [Abstract][Full Text] [Related]
7. [Expression and significance of Survivin and Smac in ovarian mucinous tumors].
Wang HX; Chen G; Li GL; Jiang YJ
Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):387-90. PubMed ID: 21055155
[TBL] [Abstract][Full Text] [Related]
8. Expression of c-myc and mutation of the KRAS gene in patients with ovarian mucinous tumors.
Li XS; Sun J; He XL
Genet Mol Res; 2015 Sep; 14(3):10752-9. PubMed ID: 26400304
[TBL] [Abstract][Full Text] [Related]
9. Expression of Lysine-specific demethylase 1 in human epithelial ovarian cancer.
Chen C; Ge J; Lu Q; Ping G; Yang C; Fang X
J Ovarian Res; 2015 May; 8():28. PubMed ID: 25956476
[TBL] [Abstract][Full Text] [Related]
10. [Expression and promotor methylation of p73 gene in ovarian epithelial tumors].
Zhang YL; Guo XR; Shen DH; Cheng YX; Liang XD; Chen YX; Wang Y
Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):33-8. PubMed ID: 22455848
[TBL] [Abstract][Full Text] [Related]
11. [Expressions of Cx43 and Skp2 in epithelial ovarian tumor and their clinical significances].
Hu YQ; Liu YJ
Ai Zheng; 2005 Jan; 24(1):104-9. PubMed ID: 15642212
[TBL] [Abstract][Full Text] [Related]
12. Expression of metallothionein and nuclear size in discrimination of malignancy in mucinous ovarian tumors.
Tan Y; Sinniah R; Bay BH; Singh G
Int J Gynecol Pathol; 1999 Oct; 18(4):344-50. PubMed ID: 10542943
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of pancreatic adenocarcinoma upregulated factor (PAUF) is associated with poor prognosis and chemoresistance in epithelial ovarian cancer.
Choi CH; Kang TH; Song JS; Kim YS; Chung EJ; Ylaya K; Kim S; Koh SS; Chung JY; Kim JH; Hewitt SM
Sci Rep; 2018 Aug; 8(1):12161. PubMed ID: 30111860
[TBL] [Abstract][Full Text] [Related]
14. Expression and mutational analysis of c-kit in ovarian surface epithelial tumors.
Kim DJ; Lee MH; Park TI; Bae HI
J Korean Med Sci; 2006 Feb; 21(1):81-5. PubMed ID: 16479070
[TBL] [Abstract][Full Text] [Related]
15. The frequency and prognostic role of P53 and P16 immunoexpression in primary ovarian mucinous tumors.
Nergiz D; Yıldırım HT; Süren D; Sadullahoğlu C; Yıldırım Ş; Üreyen I
Ann Diagn Pathol; 2024 Oct; 72():152330. PubMed ID: 38772285
[TBL] [Abstract][Full Text] [Related]
16. Claudin-18 overexpression in intestinal-type mucinous borderline tumour of the ovary.
Halimi SA; Maeda D; Shinozaki-Ushiku A; Koso T; Matsusaka K; Tanaka M; Arimoto T; Oda K; Kawana K; Yano T; Fujii T; Fukayama M
Histopathology; 2013 Oct; 63(4):534-44. PubMed ID: 23905715
[TBL] [Abstract][Full Text] [Related]
17. Axl and prostasin are biomarkers for prognosis of ovarian adenocarcinoma.
Chen PX; Li QY; Yang Z
Ann Diagn Pathol; 2013 Oct; 17(5):425-9. PubMed ID: 23707658
[TBL] [Abstract][Full Text] [Related]
18. Low Expression of CD44 Is an Independent Factor of Poor Prognosis in Ovarian Mucinous Carcinoma.
Matuura H; Miyamoto M; Takano M; Soyama H; Aoyama T; Yoshikawa T; Kato K; Sakamoto T; Kuwahara M; Takasaki K; Ishibashi H; Iwahashi H; Tsuda H; Furuya K
Anticancer Res; 2018 Feb; 38(2):717-722. PubMed ID: 29374695
[TBL] [Abstract][Full Text] [Related]
19. [Correlation of hK6 expression with clinicopathological features and prognosis in epithelial ovarian cancer].
Hu CJ; Zhang F; Chen YJ; Sun XM; Zheng JF
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):520-3. PubMed ID: 19950700
[TBL] [Abstract][Full Text] [Related]
20. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type.
Moh M; Krings G; Ates D; Aysal A; Kim GE; Rabban JT
Am J Surg Pathol; 2016 Mar; 40(3):419-32. PubMed ID: 26551622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
